ClearNote Health Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 49

Employees

  • Latest Deal Type
  • Series D

  • Latest Deal Amount
  • $52M

  • Investors
  • 4

ClearNote Health General Information

Description

Developer of a proprietary epigenomic technology designed to detect high-mortality cancers at an early, more treatable stage through a standard blood draw. The company's technology offers non-invasive, cell-free DNA-based assays that track dynamic biological changes using biomarkers and artificial intelligence, enabling high-risk individuals, such as those with newly diagnosed type 2 diabetes or predisposition to pancreatic and ovarian cancers, to access early detection and improved treatment outcomes.

Contact Information

Formerly Known As
Bluestar Genomics
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 10578 Science Center Drive
  • Suite 210
  • San Diego, CA 92121
  • United States
+1 (833)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 10578 Science Center Drive
  • Suite 210
  • San Diego, CA 92121
  • United States
+1 (833)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ClearNote Health Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series D) 27-May-2026 $52M Completed Generating Revenue
5. Later Stage VC Completed Generating Revenue
4. Later Stage VC (Series C) 12-May-2021 Completed Generating Revenue
3. Later Stage VC (Series B) Completed Generating Revenue
2. Debt - PPP 15-Apr-2020 $4.95M $5M Completed Generating Revenue
1. Early Stage VC (Series A) $5M $5M Completed Startup
To view ClearNote Health’s complete valuation and funding history, request access »

ClearNote Health Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series D-1
Series D
Series C
Series B 3,333,332 $0.000100 5% $3 $3 1x $3 9.84%
Series A 5,000,000 $0.000100 5% $1 $1 1x $1 14.76%
To view ClearNote Health’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

ClearNote Health Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ClearNote Health Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Angel (individual) Minority
Angel (individual) Minority
Pathology Asia Holdings PE-Backed Company Minority
Prosperity Capital Management Hedge Fund Minority
To view ClearNote Health’s complete investors history, request access »

ClearNote Health FAQs

  • When was ClearNote Health founded?

    ClearNote Health was founded in 2016.

  • Where is ClearNote Health headquartered?

    ClearNote Health is headquartered in San Diego, CA.

  • What is the size of ClearNote Health?

    ClearNote Health has 49 total employees.

  • What industry is ClearNote Health in?

    ClearNote Health’s primary industry is Drug Discovery.

  • Is ClearNote Health a private or public company?

    ClearNote Health is a Private company.

  • What is the current valuation of ClearNote Health?

    The current valuation of ClearNote Health is .

  • What is ClearNote Health’s current revenue?

    The current revenue for ClearNote Health is .

  • How much funding has ClearNote Health raised over time?

    ClearNote Health has raised $180M.

  • Who are ClearNote Health’s investors?

    , , Pathology Asia Holdings, and Prosperity Capital Management have invested in ClearNote Health.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process